Erkenntnisse aus dem Krankheitsverlauf von Patienten, sowie beginnende neue oder abgeschlossene Studien.
Wuhan:
Chinesische Studie zu Risikofaktoren und Letalität.
https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2930566-3
China: Serumtherapie
https://www.pnas.org/content/pnas/early/2020/04/02/2004168117.full.pdf
München:
Belgisch-niederländische Studie zum notwenigen Abstand gegen Infektionen
http://www.urbanphysics.net/Social Distancing v20_White_Paper.pdf
https://www.dw.com/de/corona-und-sport-zwei-meter-reichen-nicht/a-53076008?utm_source=pocket-newtab
https://www.nature.com/articles/s41586-020-2196-x_reference.pdf
Menschen als Laborratten?
https://science.sciencemag.org/content/early/2020/03/20/science.abb3405
US-Studie zu: Feinstaubbelastung und Letalitätsrate
https://projects.iq.harvard.edu/files/covid-pm/files/pm_and_covid_mortality.pdf
Stickodixide un Covid-19
https://www.sciencedirect.com/science/article/pii/S0048969720321215
Universitätsklinik Schleswig-Holstein: https://www.covid19trial.de/
Ernährungsstudie zur Verbesserung des Verlaufs von COVID-19
https://www.uksh.de/pi_20200331_Ernährungsstudie-path-13576,9874,13830,182668.html
NIH clinical trial of remdesivir to treat COVID-19 begins
https://www.nih.gov/news-events/news-releases/nih-clinical-trial-remdesivir-treat-covid-19-begins
Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) (COVID-19)
https://clinicaltrials.gov/ct2/show/NCT04322682
Covid-19 und 5G?
https://kompetenzinitiative.com/wp-content/uploads/2019/08/KI_FB_2019_04_01_Hecht_web.pdf
Ergebnisse der Heinsberg-Studie
https://www.uni-bonn.de/neues/111-2020https://www.ukbonn.de/C12582D3002FD21D/vwLookupDownloads/Streeck_et_al_Infection_fatality_rate_of_SARS_CoV_2_infection2.pdf/%24FILE/Streeck_et_al_Infection_fatality_rate_of_SARS_CoV_2_infection2.pdf
Verkürzte Lebensdauer von Risikopatienten nach einer Covid-19 Erkrankung
https://wellcomeopenresearch.org/articles/5-75
Selenstatus und Covid-19 Sterblichkeit
https://academic.oup.com/ajcn/advance-article/doi/10.1093/ajcn/nqaa095/5826147
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City
Area
https://www.ncbi.nlm.nih.gov/pubmed/32320003
Häufige Todesursache bei Covid-19: Lungenthrombosen:
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177070/
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis
http://www.sah.org.ar/pdf/covid-19/083-20_pre-publishing.pdf
Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands
https://pubs.rsna.org/doi/10.1148/radiol.2020201629
Anticoagulation in COVID-19
https://academic.oup.com/ehjcvp/advance-article/doi/10.1093/ehjcvp/pvaa036/5827239
Incidence of thrombotic complications in critically ill ICU patients with Covid-19
https://www.thrombosisresearch.com/article/S0049-3848(20)30120-1/pdf
A NEW VASCULITIS AT THE TIME OF COVID-19 (Focusartikel)
https://www.ejpd.com/images/nuova-vasculite-covid-ENG.pdf
Covid-19 Erkrankte sind nur 11 Tage nach dem Auftreten der ersten Symptome ansteckend:
Blutmarker zur Vorhersage eines schweren Covid-19 Verlaufs:
Longitudinal characteristics of lymphocyte responses and cytokineprofiles in the peripheral blood of SARS-CoV-2 infected patients
https://www.thelancet.com/pdfs/journals/ebiom/PIIS2352-3964(20)30138-9.pdfhttps://www.focus.de/gesundheit/news/essener-forscher-blutbild-zeigt-ob-corona-infektion-mild-oder-schwer-verlaeuft_id_12037760.html
Menschen mit Blutgruppe A sind besonders Corona-gefährdet